BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kim MW, Kwon SH, Choi JH, Lee A. A Promising Biocompatible Platform: Lipid-Based and Bio-Inspired Smart Drug Delivery Systems for Cancer Therapy. Int J Mol Sci 2018;19:E3859. [PMID: 30518027 DOI: 10.3390/ijms19123859] [Cited by in Crossref: 14] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Chaudhuri A, Kumar DN, Shaik RA, Eid BG, Abdel-Naim AB, Md S, Ahmad A, Agrawal AK. Lipid-Based Nanoparticles as a Pivotal Delivery Approach in Triple Negative Breast Cancer (TNBC) Therapy. Int J Mol Sci 2022;23:10068. [PMID: 36077466 DOI: 10.3390/ijms231710068] [Reference Citation Analysis]
2 Zhao Y, Liu T, Zhou M. Immune-Cell-Derived Exosomes for Cancer Therapy. Mol Pharm 2022. [PMID: 35876318 DOI: 10.1021/acs.molpharmaceut.2c00407] [Reference Citation Analysis]
3 Nakamura T, Sato Y, Yamada Y, Abd Elwakil MM, Kimura S, Younis MA, Harashima H. Extrahepatic targeting of lipid nanoparticles in vivo with intracellular targeting for future nanomedicines. Adv Drug Deliv Rev 2022;:114417. [PMID: 35787389 DOI: 10.1016/j.addr.2022.114417] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Côrte-real L, Brás AR, Pilon A, Mendes N, Ribeiro AS, Martins TD, Farinha JPS, Oliveira MC, Gärtner F, Garcia MH, Preto A, Valente A. Biotinylated Polymer-Ruthenium Conjugates: In Vitro and In Vivo Studies in a Triple-Negative Breast Cancer Model. Pharmaceutics 2022;14:1388. [DOI: 10.3390/pharmaceutics14071388] [Reference Citation Analysis]
5 Ryall C, Duarah S, Chen S, Yu H, Wen J. Advancements in Skin Delivery of Natural Bioactive Products for Wound Management: A Brief Review of Two Decades. Pharmaceutics 2022;14:1072. [DOI: 10.3390/pharmaceutics14051072] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
6 Naziris N, Demetzos C. Lipid Nanoparticles as Platforms for Theranostic Purposes: Recent Advances in the Field. JNT 2022;3:86-101. [DOI: 10.3390/jnt3020006] [Reference Citation Analysis]
7 Srivastava A, Rathore S, Munshi A, Ramesh R. Organically derived exosomes as carriers of anticancer drugs and imaging agents for cancer treatment. Seminars in Cancer Biology 2022. [DOI: 10.1016/j.semcancer.2022.02.020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
8 Bukhari SZ, Zeth K, Iftikhar M, Rehman M, Usman Munir M, Khan WS, Ihsan A. Supramolecular lipid nanoparticles as delivery carriers for non-invasive cancer theranostics. Curr Res Pharmacol Drug Discov 2021;2:100067. [PMID: 34909685 DOI: 10.1016/j.crphar.2021.100067] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Hussain Z, Rahim MA, Jan N, Shah H, Rawas-Qalaji M, Khan S, Sohail M, Thu HE, Ramli NA, Sarfraz RM, Abourehab MAS. Cell membrane cloaked nanomedicines for bio-imaging and immunotherapy of cancer: Improved pharmacokinetics, cell internalization and anticancer efficacy. J Control Release 2021;335:130-57. [PMID: 34015400 DOI: 10.1016/j.jconrel.2021.05.018] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
10 Bochicchio S, Lamberti G, Barba AA. Polymer-Lipid Pharmaceutical Nanocarriers: Innovations by New Formulations and Production Technologies. Pharmaceutics 2021;13:198. [PMID: 33540659 DOI: 10.3390/pharmaceutics13020198] [Cited by in Crossref: 2] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
11 Emir Diltemiz S, Tavafoghi M, de Barros NR, Kanada M, Heinämäki J, Contag C, Seidlits SK, Ashammakhi N. Use of artificial cells as drug carriers. Mater Chem Front 2021;5:6672-92. [DOI: 10.1039/d1qm00717c] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Jha A, Nikam AN, Kulkarni S, Mutalik SP, Pandey A, Hegde M, Rao BSS, Mutalik S. Biomimetic nanoarchitecturing: A disguised attack on cancer cells. J Control Release 2021;329:413-33. [PMID: 33301837 DOI: 10.1016/j.jconrel.2020.12.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
13 Charbgoo F, Taghdisi SM, Yazdian‐robati R, Abnous K, Ramezani M, Alibolandi M. Aptamer‐Incorporated Nanoparticle Systems for Drug Delivery. In: Rai M, Razzaghi‐abyaneh M, Ingle AP, editors. Nanobiotechnology in Diagnosis, Drug Delivery, and Treatment. Wiley; 2020. pp. 95-112. [DOI: 10.1002/9781119671732.ch5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Zhu W, Nie X, Tao Q, Yao H, Wang DA. Interactions at engineered graft-tissue interfaces: A review. APL Bioeng 2020;4:031502. [PMID: 32844138 DOI: 10.1063/5.0014519] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 He Z, Zhang Y, Khan AR, Ji J, Yu A, Zhai G. A novel progress of drug delivery system for organelle targeting in tumour cells. J Drug Target 2021;29:12-28. [PMID: 32698651 DOI: 10.1080/1061186X.2020.1797051] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
16 Almehmady AM, Elsisi AM. Development, optimization, and evaluation of tamsulosin nanotransfersomes to enhance its permeation and bioavailability. Journal of Drug Delivery Science and Technology 2020;57:101667. [DOI: 10.1016/j.jddst.2020.101667] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
17 Surve DH, Jindal AB. Recent advances in long-acting nanoformulations for delivery of antiretroviral drugs. J Control Release 2020;324:379-404. [PMID: 32461114 DOI: 10.1016/j.jconrel.2020.05.022] [Cited by in Crossref: 15] [Cited by in F6Publishing: 21] [Article Influence: 7.5] [Reference Citation Analysis]
18 Kim MW, Lee G, Niidome T, Komohara Y, Lee R, Park YI. Platelet-Like Gold Nanostars for Cancer Therapy: The Ability to Treat Cancer and Evade Immune Reactions. Front Bioeng Biotechnol 2020;8:133. [PMID: 32158752 DOI: 10.3389/fbioe.2020.00133] [Cited by in Crossref: 14] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
19 Koryakina I, Kuznetsova DS, Zuev DA, Milichko VA, Timin AS, Zyuzin MV. Optically responsive delivery platforms: from the design considerations to biomedical applications. Nanophotonics 2020;9:39-74. [DOI: 10.1515/nanoph-2019-0423] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
20 Kebebe D, Wu Y, Zhang B, Yang J, Liu Y, Li X, Ma Z, Lu P, Liu Z, Li J. Dimeric c(RGD) peptide conjugated nanostructured lipid carriers for efficient delivery of Gambogic acid to breast cancer. Int J Nanomedicine 2019;14:6179-95. [PMID: 31447559 DOI: 10.2147/IJN.S202424] [Cited by in Crossref: 8] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
21 Wróblewska-Krepsztul J, Rydzkowski T, Michalska-Pożoga I, Thakur VK. Biopolymers for Biomedical and Pharmaceutical Applications: Recent Advances and Overview of Alginate Electrospinning. Nanomaterials (Basel) 2019;9:E404. [PMID: 30857370 DOI: 10.3390/nano9030404] [Cited by in Crossref: 64] [Cited by in F6Publishing: 75] [Article Influence: 21.3] [Reference Citation Analysis]